Health
Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults – Medical Xpress
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune re…
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published today in the New England Journal of Medicine describes the findings from the study, which was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. SARS-CoV-2 is the virus that causes COVID-19 disease.
The experimental vaccine,…
-
Noosa News21 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
General17 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News17 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News18 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland